ORBIMED ADVISORS LLC – Alnylam Pharmaceuticals, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$50.14M
portfolio value
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 250.5K shares | 50.14M | $200.16 | 250.5K |
| Q3 2018 | share | Decrease | -100.00% | -1.26M shares | -124.68M | $87.52 | 0 |
| Q2 2018 | share | 0.00% | 0 shares | -26.09M | $98.49 | 1.26M | |
| Q1 2018 | share | Increase | +34.45% | 324.36K shares | 31.14M | $119.1 | 1.26M |
| Q4 2017 | share | Decrease | -13.20% | -143.2K shares | -7.82M | $127.05 | 941.6K |
| Q3 2017 | share | Increase | +69.71% | 445.6K shares | 76.47M | $117.49 | 1.08M |
| Q2 2017 | share | Increase | +677.62% | 557K shares | 46.77M | $79.76 | 639.2K |
| Q1 2017 | share | Increase | 0.00% | 82.2K shares | 4.21M | $51.25 | 82.2K |